These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 19213606)

  • 1. Impact of transrectal ultrasound- and computed tomography-based seed localization on postimplant dosimetry in prostate brachytherapy.
    Chew MS; Xue J; Houser C; Misic V; Cao J; Cornwell T; Handler J; Yu Y; Gressen E
    Brachytherapy; 2009; 8(2):255-264. PubMed ID: 19213606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of interobserver variability on transrectal ultrasonography-based postimplant dosimetry.
    Xue J; Waterman F; Handler J; Gressen E
    Brachytherapy; 2006; 5(3):174-82. PubMed ID: 16864069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound-CT fusion compared with MR-CT fusion for postimplant dosimetry in permanent prostate brachytherapy.
    Bowes D; Crook JM; Araujo C; Batchelar D
    Brachytherapy; 2013; 12(1):38-43. PubMed ID: 22727473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy.
    Stone NN; Hong S; Lo YC; Howard V; Stock RG
    Brachytherapy; 2003; 2(1):17-25. PubMed ID: 15062159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of selection of post-implant technique on dosimetry parameters for permanent prostate implants.
    Haworth A; Ebert M; St Clair S; Carey BM; Flynn A; Bottomley DM; Duchesne GM; Joseph D; Ash D
    Brachytherapy; 2005; 4(2):146-53. PubMed ID: 15893269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the feasibility of using transrectal ultrasound for postimplant dosimetry in low-dose-rate prostate brachytherapy.
    Davies RS; Perrett T; Powell J; Barber J; Tanguay J; Button M; Cochlin D; Smith C; Lester JF
    Med Dosim; 2016 Winter; 41(4):290-295. PubMed ID: 27623391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate brachytherapy intraoperative dosimetry using a combination of radiographic seed localization with a C-arm and deformed ultrasound prostate contours.
    Golshan M; Mahdavi SS; Samei G; Lobo J; Pickles T; James Morris W; Keyes M; Peacock M; Salcudean SE; Spadinger I
    Brachytherapy; 2020; 19(5):589-598. PubMed ID: 32682777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of intraoperative ultrasound with postimplant computed tomography--dosimetric values at Day 1 and Day 30 after prostate brachytherapy.
    Ohashi T; Yorozu A; Toya K; Saito S; Momma T; Nagata H; Kosugi M; Shigematsu N; Kubo A
    Brachytherapy; 2007; 6(4):246-53. PubMed ID: 17959425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate brachytherapy postimplant dosimetry: seed orientation and the impact of dosimetric anisotropy in stranded implants.
    Chng N; Spadinger I; Rasoda R; Morris WJ; Salcudean S
    Med Phys; 2012 Feb; 39(2):721-31. PubMed ID: 22320782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The applicability of simultaneous TRUS-CT imaging for the evaluation of prostate seed implants.
    Steggerda M; Schneider C; van Herk M; Zijp L; Moonen L; van der Poel H
    Med Phys; 2005 Jul; 32(7):2262-70. PubMed ID: 16121581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative Registered Ultrasound and Fluoroscopy (iRUF) for dose calculation during prostate brachytherapy: Improved accuracy compared to standard ultrasound-based dosimetry.
    Lee J; Mian OY; Le Y; Bae HJ; Burdette EC; DeWeese TL; Prince JL; Song DY
    Radiother Oncol; 2017 Jul; 124(1):61-67. PubMed ID: 28647400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of linked 125I seeds in postimplant TRUS images for prostate brachytherapy dosimetry.
    Xue J; Waterman F; Handler J; Gressen E
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):912-9. PubMed ID: 15936577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between postoperative TRUS-CT fusion with MRI-CT fusion for postimplant quality assurance in prostate LDR permanent seed brachytherapy.
    Tisseverasinghe S; Marbán M; Crook J; Petrik D; Araujo C
    Brachytherapy; 2021; 20(4):849-856. PubMed ID: 33867295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of post-plan dosimetry using TRUS and CT after transperineal prostate seed implant.
    Helmick R; Tarver R; Chan R; Caldwell S
    Med Dosim; 2002; 27(4):289-93. PubMed ID: 12521076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT- and MRI-based seed localization in postimplant evaluation after prostate brachytherapy.
    De Brabandere M; Al-Qaisieh B; De Wever L; Haustermans K; Kirisits C; Moerland MA; Oyen R; Rijnders A; Van den Heuvel F; Siebert FA
    Brachytherapy; 2013; 12(6):580-8. PubMed ID: 23876358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate volume measurement by transrectal ultrasound and computed tomography before and after permanent prostate brachytherapy.
    Solhjem MC; Davis BJ; Pisansky TM; Wilson TM; Mynderse LA; Herman MG; King BF; Geyer SM
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):767-76. PubMed ID: 15465193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI-based preplanning in low-dose-rate prostate brachytherapy.
    Tanaka O; Hayashi S; Matsuo M; Nakano M; Kubota Y; Maeda S; Ohtakara K; Deguchi T; Hoshi H
    Radiother Oncol; 2008 Jul; 88(1):115-20. PubMed ID: 17933407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of MRI-based postimplant dosimetric assessment in prostate brachytherapy using contrast-enhanced T1-weighted images.
    Ohashi T; Momma T; Yamashita S; Nagatsuma K; Kanai K; Kitagawa K; Takahashi S; Hanada T; Yorozu A; Shigematsu N
    Brachytherapy; 2012; 11(6):468-75. PubMed ID: 22330102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computing intraoperative dosimetry for prostate brachytherapy using TRUS and fluoroscopy.
    French D; Morris J; Keyes M; Goksel O; Salcudean S
    Acad Radiol; 2005 Oct; 12(10):1262-72. PubMed ID: 16179203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of clinically relevant dosimetric parameters to contouring uncertainty in postimplant dosimetry of low-dose-rate prostate permanent seed brachytherapy.
    Mashouf S; Safigholi H; Merino T; Soliman A; Ravi A; Morton G; Song WY
    Brachytherapy; 2016; 15(6):774-779. PubMed ID: 27720310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.